This website contains forward-looking statements about our business. These forward-looking statements do not relate strictly to historical or current facts and they may be accompanied by such words as “aim,” “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “potential,” “possible,” “will” and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early stage trials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval. These forward-looking statements are necessarily estimates reflecting the best judgment of our leadership team based upon current information available when the statements were made. You should not put undue reliance on these statements or the scientific data presented. Our actual results may differ materially from the results anticipated. These forward-looking statements are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.